professional fluorecare® – SARS-CoV-2 & Infl. A/B & RSV Combined Test
- Article ID
- MF-71-25
- Handling time
- / /
SHARE:
Product description
The fluorecare® SARS-CoV-2 & Influenza A/B & RSV Antigen Combined Test Kit is applicable to the simultaneous qualitative detection and differentiation of novel Coronavirus (SARS-CoV-2 Antigen), Influenza A virus, Influenza B virus Antigen and/or RSV Antigen in population Oropharyngeal swabs, Nasal swabs and Nasopharyngeal swabs samples in vitro. For professional use only. For prescription use only. For in vitro diagnostic use only.
Principle
The SARS-CoV-2 & Influenza A/B & RSV Antigen is qualitatively detected in population Oropharyngeal swabs, Nasal swabs or Nasopharyngeal swabs samples by the colloidal gold method. After sample added, the SARS-CoV-2 Antigen (or Influenza A/B & RSV) in the sample to be tested is combined with the SARS-CoV-2 Antigen (or Influenza A/B & RSV) antibody labelled with colloidal gold on the binding pad to form the SARS-CoV-2 Antigen (or Influenza A/B & RSV) antibody-colloidal gold complex. Due to chromatography, the SARS-CoV-2 Antigen (or Influenza A/B & RSV)-antibody-colloidal gold complex diffuses along the nitrocellulose’s membrane. Within the detection line area, the SARS-CoV-2 Antigen (or Influenza A/B & RSV)-antibody complex binds to the antibody enclosed within the detection line area, showing a purple-red band. Colloidal gold labelled SARS-CoV-2 Antigen (or Influenza A/B & RSV) antibody diffuses to the quality control line (C) region and is captured by sheep anti-mouse IgG to form red bands. When the reaction is over, the results can be interpreted by visual observation.
SHARE:
